Previous research has shown that lidocaine has antiproliferative effects on colorectal cancer cells (SW480 and HCT116), causing cell death by suppressing the EGFR through the upregulation of miR-520a-3p, which targets EGFR [37]. The gene discussed is EGFR; the disease is colorectal cancer.